Src is a novel potential off-target of RXR agonists, 9-cis-UAB30 and Targretin, in human breast cancer cells

Mi Sung Kim, Do Young Lim, Jong Eun Kim, Hanyong Chen, Ronald A. Lubet, Zigang Dong, Ann M. Bode

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Src is a novel potential off-target of RXR agonists, 9-cis-UAB30 and Targretin, in human breast cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences